Agenda Topics Include
- Company building at a time of unprecedented change and uncertainty
- Venture investing in a post-COVID world
- The $BB Club: Hear from CEOs fueling the historic recent run of medtech mega-exits
- Perspectives on cross-over financings, IPOs, and SPACs
- Corporate development roundtable: What are strategics prioritizing in the new normal?
- The emergence of data science as a core medtech pillar
- View from the Beltway: What should we expect from the new administration, FDA, and CMS?
- Multiple 1:1 discussions with leading medtech CEOs